Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes

Benjamin R Wakerley1, Nobuhiro Yuki2

  • 1Department of Neurology, Gloucestershire Royal Hospital, Gloucester, UK.

Practical Neurology
|September 21, 2014
PubMed

Insights

Guillain-Barré syndrome (GBS) and Miller Fisher syndrome (MFS) are related disorders with overlapping features. Recognizing their spectrum and atypical presentations is crucial for accurate diagnosis and timely immunotherapy.

Area of Science:

  • Neurology
  • Immunology

Background:

  • Guillain-Barré syndrome (GBS) and Miller Fisher syndrome (MFS) are heterogeneous neurological disorders.
  • These conditions form a spectrum with shared pathophysiological mechanisms and clinical features.

Purpose of the Study:

  • To highlight the pathophysiological relationship and overlapping clinical features of GBS and MFS.
  • To discuss diagnostic challenges, mimics, and atypical presentations of GBS-related disorders.

Main Methods:

  • Review of clinical features, diagnostic criteria, and differential diagnoses for GBS and MFS.
  • Analysis of common and atypical presentations, including mimics.

Main Results:

  • GBS and MFS share features like antecedent infection, monophasic course, and weakness.
  • Diagnostic support includes CSF albuminocytological dissociation, antibodies, and neurophysiology, but these are not definitive.
  • Mimics include stroke, botulism, myasthenia gravis, and Wernicke's encephalopathy; atypical GBS presentations exist.

Conclusions:

  • Accurate diagnosis of GBS-related disorders is essential to avoid unnecessary tests.
  • Early immunotherapy can be initiated promptly upon correct diagnosis.
Keywords:
NEUROPATHY

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.2K
Nonconscious Mimicry01:13

Nonconscious Mimicry

Nonconscious mimicry occurs when individuals alter their mannerisms to match the behaviors and expressions of those nearby, without intention.
3.6K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
34
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.2K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.8K